Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FKMSA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,408
Award facts
- Contract value 100% obligated
- $9,408.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,408.43 delivery order to AmerisourceBergen Drug Corp for GEMTESA 75 MG tablets (90-count units) on July 24, 2025, with a completion date of July 25, 2025. This firm fixed-price contract represents a non-competed award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order falls under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX and running through December 2026), which enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. GEMTESA (mirabegron), a urological medication, aligns with the contractor's established portfolio of specialty pharmaceuticals and brand-name drugs delivered across multiple therapeutic domains to the Defense Health Agency and other federal healthcare systems. The award reflects the company's ongoing role as a prime vendor in the DLA's pharmaceutical support operations.
Quick answers
Who was awarded contract SPE2DB25FKMSA?
SPE2DB25FKMSA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FKMSA worth?
The government has obligated $9,408 on SPE2DB25FKMSA.
Is contract SPE2DB25FKMSA an order under another contract?
Yes. SPE2DB25FKMSA is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKMSA competed?
The extent of competition for SPE2DB25FKMSA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award